A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

Here are nine new drug shortages to know, according to databases compiled by the FDA and the American Society of Health-System Pharmacists. Albuterol sulfate syrup ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

The FDA proposed a ban on phenylephrine, a common decongestant found in cold and cough medications. Here’s why and a list of ...

While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...